immune primer

Ilixadencel improves responses and survival in metastatic kidney cancer

By Sharon Kell|2020-02-21T10:34:30+00:0021 Feb 2020|Drug treatments|

Results from a recent phase 2 clinical trial of ilixadencel [...]

Comments Off

Follow-up data from phase I/II clinical trial with INTUVAX in kidney cancer shows promise

By Sharon Kell|2016-06-16T13:44:15+00:0016 Jun 2016|Drug treatments|

Follow-up data from a phase I/II clinical trial with INTUVAX [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Health Information Policy

Follow

Web Design by Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org